Account-creators
1,040
edits
Difference between revisions of "Ganglioglioma"
Jump to navigation
Jump to search
→General
Jensflorian (talk | contribs) (molecular update) |
Jensflorian (talk | contribs) |
||
| Line 40: | Line 40: | ||
*Recognized as a cause of [[epilepsy]].<ref name=pmid12125968>{{Cite journal | last1 = Im | first1 = SH. | last2 = Chung | first2 = CK. | last3 = Cho | first3 = BK. | last4 = Lee | first4 = SK. | title = Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome. | journal = J Neurooncol | volume = 57 | issue = 1 | pages = 59-66 | month = Mar | year = 2002 | doi = | PMID = 12125968 }}</ref> | *Recognized as a cause of [[epilepsy]].<ref name=pmid12125968>{{Cite journal | last1 = Im | first1 = SH. | last2 = Chung | first2 = CK. | last3 = Cho | first3 = BK. | last4 = Lee | first4 = SK. | title = Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome. | journal = J Neurooncol | volume = 57 | issue = 1 | pages = 59-66 | month = Mar | year = 2002 | doi = | PMID = 12125968 }}</ref> | ||
*Favourable prognosis (survival rates up to 97%) | *Favourable prognosis (survival rates up to 97%) | ||
** | **Anaplastic ganglioglioma have a recurrence risk of 69%<ref>{{Cite journal | last1 = Terrier | first1 = LM. | last2 = Bauchet | first2 = L. | last3 = Rigau | first3 = V. | last4 = Amelot | first4 = A. | last5 = Zouaoui | first5 = S. | last6 = Filipiak | first6 = I. | last7 = Caille | first7 = A. | last8 = Almairac | first8 = F. | last9 = Aubriot-Lorton | first9 = MH. | title = Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. | journal = Neuro Oncol | volume = 19 | issue = 5 | pages = 678-688 | month = 05 | year = 2017 | doi = 10.1093/neuonc/now186 | PMID = 28453747 }}</ref> | ||
==Imaging== | ==Imaging== | ||